Behçet disease-associated rhabdomyolysis treated with infliximab

Intern Med J. 2020 May;50(5):642-643. doi: 10.1111/imj.14827.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antirheumatic Agents* / therapeutic use
  • Behcet Syndrome* / complications
  • Behcet Syndrome* / diagnosis
  • Behcet Syndrome* / drug therapy
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Infliximab / therapeutic use
  • Rhabdomyolysis* / chemically induced
  • Rhabdomyolysis* / drug therapy
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha

Substances

  • Antirheumatic Agents
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab